Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug AZD1163 aims to ease rheumatoid arthritis pain

NCT ID NCT07276581

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an experimental drug called AZD1163 in 320 people with moderate-to-severe rheumatoid arthritis who haven't gotten enough relief from standard treatments. Participants receive either AZD1163 or a placebo as an injection, along with their usual care. The main goal is to see if AZD1163 reduces joint swelling and tenderness after 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AZD1163 (an experimental drug given as an injection under the skin)
What this could lead to
If it works, this could lead to a new treatment option for people with rheumatoid arthritis who haven't responded well to standard therapies.
What could go wrong
This is an early Phase 2 trial with only 320 participants, so results may not apply to everyone. The drug may not work better than placebo, and side effects are still being studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 320 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* Inclusion * Diagnosed with adult-onset RA as defined by the 2010 ACR/EULAR classification criteria for at least 12 weeks prior to screening. * Moderately-to-severely active RA as defined by: a. \>= 6 swollen joints on 66SJC and \>= 6 tender joints on 68TJC; b. CRP \> upper limit of normal. * Have a positive ACPA at screening. * A history of inadequate response, or loss of response, or intolerance to: a. at least one csDMARD treatment, AND/OR b. At least one and at most 2 TNFi. * A history of at least 12 weeks treatment and \>= 4 weeks stable on a csDMARD and/or SC TNFi prior to the day of randomisation. * Exclusion * History or evidence of an alternate autoimmune or other condition that could confound the diagnosis of RA. Participants with RA and secondary Sjogren's disease are eligible. * Have received or planning to receive any biologic DMARDs (except for TNFi) or targeted synthetic DMARDs.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rheumatoid arthritis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    134 sites in 17 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Research Site

    NOT_YET_RECRUITING

    Glendale, Arizona, 85306, United States

  • Research Site

    WITHDRAWN

    Prescott Valley, Arizona, 86314, United States

  • Research Site

    NOT_YET_RECRUITING

    Tucson, Arizona, 85748, United States

  • Research Site

    NOT_YET_RECRUITING

    La Jolla, California, 92037, United States

  • Research Site

    WITHDRAWN

    San Dimas, California, 91773, United States

  • Research Site

    NOT_YET_RECRUITING

    San Leandro, California, 94578, United States

  • Research Site

    NOT_YET_RECRUITING

    Aurora, Colorado, 80045, United States

  • Research Site

    WITHDRAWN

    Boynton Beach, Florida, 33435, United States

  • Research Site

    WITHDRAWN

    Jacksonville, Florida, 32216, United States

  • Research Site

    SUSPENDED

    South Miami, Florida, 33143, United States

  • Research Site

    WITHDRAWN

    Tampa, Florida, 33607, United States

  • Research Site

    NOT_YET_RECRUITING

    Winter Haven, Florida, 33880, United States

  • Research Site

    NOT_YET_RECRUITING

    Marietta, Georgia, 30060, United States

  • Research Site

    NOT_YET_RECRUITING

    Skokie, Illinois, 60076, United States

  • Research Site

    RECRUITING

    Willowbrook, Illinois, 60527, United States

  • Research Site

    RECRUITING

    Lake Charles, Louisiana, 70605, United States

  • Research Site

    NOT_YET_RECRUITING

    Baltimore, Maryland, 21224, United States

  • Research Site

    RECRUITING

    New Bedford, Massachusetts, 02740, United States

  • Research Site

    NOT_YET_RECRUITING

    Kansas City, Missouri, 64151, United States

  • Research Site

    RECRUITING

    St Louis, Missouri, 63131, United States

  • Research Site

    RECRUITING

    Henderson, Nevada, 89052, United States

  • Research Site

    NOT_YET_RECRUITING

    Myrtle Beach, South Carolina, 29572, United States

  • Research Site

    RECRUITING

    Austin, Texas, 78745, United States

  • Research Site

    RECRUITING

    Baytown, Texas, 77521, United States

  • Research Site

    RECRUITING

    Houston, Texas, 77027, United States

  • Research Site

    RECRUITING

    Houston, Texas, 77089, United States

  • Research Site

    NOT_YET_RECRUITING

    Mesquite, Texas, 75150, United States

  • Research Site

    RECRUITING

    Tomball, Texas, 77375, United States

  • Research Site

    RECRUITING

    Caba, C1128AAF, Argentina

  • Research Site

    RECRUITING

    Ciudad de Buenos Aires, C1015ABO, Argentina

  • Research Site

    NOT_YET_RECRUITING

    Ciudad de Buenos Aires, C1428DUQ, Argentina

  • Research Site

    RECRUITING

    Córdoba, X5000EDC, Argentina

  • Research Site

    RECRUITING

    San Isidro, 1643, Argentina

  • Research Site

    RECRUITING

    San Miguel de Tucumán, T4000AXL, Argentina

  • Research Site

    NOT_YET_RECRUITING

    Juiz de Fora, 36010 570, Brazil

  • Research Site

    NOT_YET_RECRUITING

    Pelotas, 96040-010, Brazil

  • Research Site

    NOT_YET_RECRUITING

    Porto Alegre, 90035-903, Brazil

  • Research Site

    NOT_YET_RECRUITING

    Porto Alegre, 9061-000, Brazil

  • Research Site

    NOT_YET_RECRUITING

    Salvador, 41820-020, Brazil

  • Research Site

    WITHDRAWN

    São Paulo, 04266-010, Brazil

  • Research Site

    NOT_YET_RECRUITING

    São Paulo, 05403-9000, Brazil

  • Research Site

    NOT_YET_RECRUITING

    Haskovo, 6304, Bulgaria

  • Research Site

    NOT_YET_RECRUITING

    Pleven, 5800, Bulgaria

  • Research Site

    NOT_YET_RECRUITING

    Sofia, 1113, Bulgaria

  • Research Site

    NOT_YET_RECRUITING

    Sofia, 1336, Bulgaria

  • Research Site

    NOT_YET_RECRUITING

    Sofia, 1606, Bulgaria

  • Research Site

    NOT_YET_RECRUITING

    Sofia, 1612, Bulgaria

  • Research Site

    RECRUITING

    Windsor, Ontario, N8X 5A7, Canada

  • Research Site

    RECRUITING

    Trois-Rivières, Quebec, G9A 3Y2, Canada

  • Research Site

    NOT_YET_RECRUITING

    Providencia, 7510186, Chile

  • Research Site

    NOT_YET_RECRUITING

    Santiago, 7500571, Chile

  • Research Site

    NOT_YET_RECRUITING

    Santiago, 7500587, Chile

  • Research Site

    NOT_YET_RECRUITING

    Temuco, 4810345, Chile

  • Research Site

    NOT_YET_RECRUITING

    Valdivia, 5110683, Chile

  • Research Site

    NOT_YET_RECRUITING

    Victoria, 4720097, Chile

  • Research Site

    NOT_YET_RECRUITING

    Viña del Mar, 2531172, Chile

  • Research Site

    NOT_YET_RECRUITING

    Beijing, 100144, China

  • Research Site

    RECRUITING

    Beijing, 100730, China

  • Research Site

    NOT_YET_RECRUITING

    Changchun, 130021, China

  • Research Site

    NOT_YET_RECRUITING

    Changsha, 410008, China

  • Research Site

    NOT_YET_RECRUITING

    Guangzhou, 510515, China

  • Research Site

    NOT_YET_RECRUITING

    Jiujiang, 332000, China

  • Research Site

    NOT_YET_RECRUITING

    Kunming, 650032, China

  • Research Site

    RECRUITING

    Linyi, CN-276003, China

  • Research Site

    RECRUITING

    Nanchong, 637000, China

  • Research Site

    RECRUITING

    Panjin, 124000, China

  • Research Site

    RECRUITING

    Pingxiang, 337055, China

  • Research Site

    NOT_YET_RECRUITING

    Shantou, 515041, China

  • Research Site

    NOT_YET_RECRUITING

    Xuzhou, 221009, China

  • Research Site

    NOT_YET_RECRUITING

    Yangzhou, 225001, China

  • Research Site

    NOT_YET_RECRUITING

    Zhengzhou, 450000, China

  • Research Site

    NOT_YET_RECRUITING

    Bad Doberan, 18209, Germany

  • Research Site

    NOT_YET_RECRUITING

    Berlin, 10777, Germany

  • Research Site

    NOT_YET_RECRUITING

    Hamburg, 20095, Germany

  • Research Site

    NOT_YET_RECRUITING

    Sendenhorst, 48324, Germany

  • Research Site

    NOT_YET_RECRUITING

    Budapest, 1023, Hungary

  • Research Site

    NOT_YET_RECRUITING

    Budapest, 1027, Hungary

  • Research Site

    NOT_YET_RECRUITING

    Budapest, 1036, Hungary

  • Research Site

    NOT_YET_RECRUITING

    Debrecen, 4032, Hungary

  • Research Site

    NOT_YET_RECRUITING

    Gyula, 5700, Hungary

  • Research Site

    NOT_YET_RECRUITING

    Szeged, 6725, Hungary

  • Research Site

    NOT_YET_RECRUITING

    Székesfehérvár, 8000, Hungary

  • Research Site

    NOT_YET_RECRUITING

    Veszprém, 8200, Hungary

  • Research Site

    NOT_YET_RECRUITING

    Aomori, 030-8553, Japan

  • Research Site

    NOT_YET_RECRUITING

    Bunkyō City, 113-8655, Japan

  • Research Site

    RECRUITING

    Fukuoka, 815-8555, Japan

  • Research Site

    RECRUITING

    Hamamatsu, 430-0906, Japan

  • Research Site

    RECRUITING

    Hitachi-Naka, 312-0057, Japan

  • Research Site

    RECRUITING

    Iizuka-shi, 820-8505, Japan

  • Research Site

    RECRUITING

    Kawachinagano-shi, 586-8521, Japan

  • Research Site

    NOT_YET_RECRUITING

    Matsuyama, 790-8524, Japan

  • Research Site

    RECRUITING

    Meguro-ku, 152-8902, Japan

  • Research Site

    RECRUITING

    Miyazaki, 880-0834, Japan

  • Research Site

    RECRUITING

    Nagoya, 457-8511, Japan

  • Research Site

    WITHDRAWN

    Okayama, 700-8557, Japan

  • Research Site

    RECRUITING

    Sagamihara-shi, 252-0315, Japan

  • Research Site

    WITHDRAWN

    Sapporo, 060-0001, Japan

  • Research Site

    RECRUITING

    Sasebo-shi, 857-1195, Japan

  • Research Site

    RECRUITING

    Sayama-shi, 350-1305, Japan

  • Research Site

    NOT_YET_RECRUITING

    Yokohama, 236-0037, Japan

  • Research Site

    NOT_YET_RECRUITING

    Chihuahua City, 31000, Mexico

  • Research Site

    NOT_YET_RECRUITING

    Estado de México, 50090, Mexico

  • Research Site

    NOT_YET_RECRUITING

    Guadalajara, 44160, Mexico

  • Research Site

    NOT_YET_RECRUITING

    Guadalajara, 44650, Mexico

  • Research Site

    NOT_YET_RECRUITING

    Guadalajara, 44690, Mexico

  • Research Site

    NOT_YET_RECRUITING

    Gustavo A. Madero, 07300, Mexico

  • Research Site

    NOT_YET_RECRUITING

    Mexicali, 021100, Mexico

  • Research Site

    NOT_YET_RECRUITING

    Mexico City, 06700, Mexico

  • Research Site

    NOT_YET_RECRUITING

    Mérida, 97070, Mexico

  • Research Site

    NOT_YET_RECRUITING

    Monterrey, 64460, Mexico

  • Research Site

    WITHDRAWN

    San Luis Potosí City, 78213, Mexico

  • Research Site

    NOT_YET_RECRUITING

    Krakow, 30-002, Poland

  • Research Site

    NOT_YET_RECRUITING

    Krakow, 30-727, Poland

  • Research Site

    NOT_YET_RECRUITING

    Torun, 87-100, Poland

  • Research Site

    NOT_YET_RECRUITING

    Warsaw, 00-874, Poland

  • Research Site

    NOT_YET_RECRUITING

    Wroclaw, 50-244, Poland

  • Research Site

    NOT_YET_RECRUITING

    Caguas, 00725, Puerto Rico

  • Research Site

    WITHDRAWN

    Brackenfell, 7560, South Africa

  • Research Site

    NOT_YET_RECRUITING

    Cape Town, 7500, South Africa

  • Research Site

    NOT_YET_RECRUITING

    Durban, 4319, South Africa

  • Research Site

    NOT_YET_RECRUITING

    Pinelands, 7405, South Africa

  • Research Site

    NOT_YET_RECRUITING

    Pretoria, 0002, South Africa

  • Research Site

    NOT_YET_RECRUITING

    Pretoria, South Africa

  • Research Site

    NOT_YET_RECRUITING

    Somerset West, 7130, South Africa

  • Research Site

    NOT_YET_RECRUITING

    Barcelona, 08003, Spain

  • Research Site

    NOT_YET_RECRUITING

    Barcelona, 08035, Spain

  • Research Site

    NOT_YET_RECRUITING

    Barcelona, 08041, Spain

  • Research Site

    NOT_YET_RECRUITING

    Málaga, 29009, Spain

  • Research Site

    NOT_YET_RECRUITING

    Sabadell, 08208, Spain

  • Research Site

    NOT_YET_RECRUITING

    Santiago de Compostela, 15706, Spain

  • Research Site

    NOT_YET_RECRUITING

    Valencia, 46026, Spain

  • Research Site

    RECRUITING

    Ivano-Frankivsk, 76018, Ukraine

  • Research Site

    RECRUITING

    Kyiv, 02002, Ukraine

  • Research Site

    RECRUITING

    Kyiv, 03037, Ukraine

  • Research Site

    RECRUITING

    Kyiv, 03049, Ukraine

  • Research Site

    RECRUITING

    Kyiv, 04050, Ukraine

  • Research Site

    RECRUITING

    Kyiv, 04210, Ukraine

  • Research Site

    RECRUITING

    Uzhhorod, 88000, Ukraine

  • Research Site

    RECRUITING

    Vinnytsia, 21018, Ukraine

  • Research Site

    RECRUITING

    Vinnytsia, 21029, Ukraine

  • Research Site

    RECRUITING

    Glasgow, G31 2ER, United Kingdom

  • Research Site

    RECRUITING

    Leeds, LS7 4SA, United Kingdom

  • Research Site

    RECRUITING

    Luton, LU4 0DZ, United Kingdom

  • Research Site

    NOT_YET_RECRUITING

    Staffordshire, WS11 5XY, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.